**Core Concept**
The clinical presentation suggests an overdose of a drug that affects the parasympathetic nervous system, leading to increased cholinergic activity. This is characterized by symptoms such as diarrhea, urination, sweating, and respiratory difficulty, which are indicative of **muscarinic receptor** stimulation.

**Why the Correct Answer is Right**
The correct answer is likely an **organophosphate** or a **cholinesterase inhibitor**, which increases acetylcholine levels in the synaptic cleft, leading to overstimulation of **muscarinic** and **nicotinic receptors**. However, the absence of vascular or CNS effects suggests a more selective effect on muscarinic receptors, which are involved in the regulation of smooth muscle, glands, and the heart.

**Why Each Wrong Option is Incorrect**
**Option A:** May not be directly related to the specific symptoms described, lacking the characteristic cholinergic toxicity profile.
**Option B:** Could be considered, but the specific effects mentioned do not perfectly align with the expected toxicity profile.
**Option C:** May cause different types of toxicity, not matching the muscarinic-dominated picture presented.
**Option D:** Could potentially cause such effects, but without more context, it's less directly implicated in the described scenario.

**Clinical Pearl / High-Yield Fact**
In cases of suspected cholinergic toxicity, it's crucial to remember the mnemonic **SLUDGE** (Salivation, Lacrimation, Urination, Diarrhea, Gastrointestinal distress, and Emesis) to quickly identify key symptoms, although this case presents a slightly different constellation of symptoms.

**Correct Answer:** D. Organophosphate poisoning.